TIBBIYAH announces issuance of commercial registration for new company “Life Genes”

Arabian International Healthcare Holding Company (“TIBBIYAH”) announced on Monday the issuance of the commercial registration of the new company in accordance with the applicable regulations in the Kingdom of Saudi Arabia. On 12-25-2022, it was registered in the name of Medical Life Genes, where it is owned by 50% to each of “BGI Al-Manahil” and “Tabiya”.
It said in a statement on Tadawul on Monday that the transaction has sought all regulatory approvals and satisfied all condition precedents including the non-objection certificate received from General Authority of Competition.
This comes with reference to Arabian International Healthcare Holding Company (“TIBBIYAH”), a leading integrated healthcare solutions provider in the Kingdom, previously on 27 July 2022, announcing about entering into a definitive Joint Venture Agreement with BGI ALMANAHIL HEALTH FOR MEDICAL SERVICES (a subsidiary company of BGI Health (HK) Co., Ltd) in the formation and operation of a limited liability company in the Kingdom to be owned 50% by BGI ALMANAHIL HEALTH FOR MEDICAL SERVICES and 50% by TIBBIYAH, in order to provide clinical laboratory testing services and bioinformation services to hospitals, research institutes, medical centers and clinics for both in the public and private sectors.